Product Information
ATENOLOL 50 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0236 per EA under NDC 65862016901. Its NADAC has been published 449 times since Nov 28, 2013.
FDA first approved this application on Oct 31, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862016901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ATENOLOLApproval Type
Generic (ANDA)
FDA Application
ANDA078512FDA Approved
10/31/2007
TE Code
AB
On Market Since
10/31/2007
Pharmacological Classes
Price Statistics
The NADAC for ATENOLOL 50 MG TABLET has been published 449 times since Nov 28, 2013, and over the history we have for it it has risen 51.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0236 per EA |
|---|---|
| All-time high | $0.0317 (Jun 16, 2021) |
| All-time low | $0.0155 (Oct 21, 2015) |
| 52-week high | $0.0263 |
| 52-week low | $0.0236 |
| Median price | $0.0250 |
| Average price | $0.0228 |
| Largest weekly change | +90.1% (Jun 2, 2021) |
| Weeks tracked | 449 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Atenolol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATENOLOL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATENOLOL 50 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0236 per EA (NDC 65862016901), effective Sep 30, 2026.
How has the price of ATENOLOL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATENOLOL 50 MG TABLET has risen 51.1%. It has been tracked across 449 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ATENOLOL 50 MG TABLET?
Since Nov 28, 2013, the NADAC for ATENOLOL 50 MG TABLET has ranged from a low of $0.0155 (Oct 21, 2015) to a high of $0.0317 (Jun 16, 2021), with a median of $0.0250 per EA.
Are there cheaper alternatives to ATENOLOL 50 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATENOLOL 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ATENOLOL 50 MG TABLET?
ATENOLOL 50 MG TABLET (NDC 65862016901) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.